Psychosis News and Research

RSS

Psychosis means abnormal condition of the mind, and is a generic psychiatric term for a mental state often described as involving a "loss of contact with reality". People suffering from psychosis are said to be ''psychotic.''

Cannabis: CBD vs THC causes lower psychiatric side-effects

A study has revealed how cannabidiol works against tetrahydrocannabinol to prevent psychiatric side effects.

1 Oct 2019

Veterans with mental health disorders have increased risk of heart attack, stroke

Veterans with specific mental health disorders - depression , psychosis and bipolar disorder - had an increased risk of heart attack, stroke and death from cardiovascular disease, according to new research published in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

24 Sep 2019

Identification and management of depression in people with epilepsy to save lives

Depression is the most common psychiatric comorbidity in people with epilepsy. Clinical studies have found that 20% to 30% of people with epilepsy have depression; the incidence may be as high as 50% to 55% in people visiting hospital epilepsy centers.

21 Sep 2019

NIH awards research grants to develop learning health care system for early psychosis treatment

The National Institutes of Health awarded six research grants for studies to develop a learning health care system for the treatment of early psychosis.

20 Sep 2019

New uses for CBD in genetic brain disorder

A new study has revealed that cannabidiol can help people with a rare brain condition called Angelman syndrome to improve their behavioral traits and to control seizures.

19 Sep 2019

Neurological markers in the brain can help detect people at risk for psychotic disorders

Help may be on the way for people who might lose contact with reality through a psychotic disorder, such as schizophrenia.

27 Aug 2019

Study exposes major gaps in understanding the full burden of ADRD/dementia

A new research review highlighting the hidden costs of dementia suggests that traditional measures only show the ‘tip of the iceberg’ of the cost impact on society.

26 Aug 2019

Adolescents are using a highly potent form of marijuana, study finds

Nearly one in four Arizona teens have used a highly potent form of marijuana known as marijuana concentrate, according to a new study by Arizona State University researchers.

26 Aug 2019

Risk for schizophrenia and bipolar disorder has distinct effects on the brain

Brain abnormalities in people at familial risk of schizophrenia and bipolar disorder emerge in unique patterns, despite the symptom and genetic overlap of the disorders, according to a study in Biological Psychiatry, published by Elsevier.

20 Aug 2019

FDA approves effective new treatment for extremely drug-resistant tuberculosis

Tuberculosis is the leading infectious killer in the world, far above AIDS. It kills about 1.6 million of the 10 million it affects every year. About 30,000 patients worldwide now have XDR tuberculosis (that fails to respond to any of the four antibiotic categories in use at present).

15 Aug 2019

Breakthrough study identifies specific antibody target implicated in neuropsychiatric lupus

A breakthrough study by a SUNY Downstate Health Sciences University research team has identified a specific antibody target implicated in neuropsychiatric symptoms of lupus.

13 Aug 2019

Blood clotting proteins in urine act as potent biomarkers for lupus

The team of researchers at the University of Houston found that blood clotting proteins, both the ones that promote blood clotting (prothrombic) and those that disperse them (thrombolytic) are elevated in the urine of patients with lupus nephritis (LN).

7 Aug 2019

New study explores the effects of cannabis on brain neurochemistry

A new Addiction Biology study provides the first evidence of a blunted response to stress-induced dopamine signaling in the brain's prefrontal cortex in individuals at high risk for psychosis who regularly used cannabis.

7 Aug 2019

Traditional measures overlook socioeconomic costs associated with dementia

A new research review highlighting the hidden costs of dementia suggests that traditional measures only show the 'tip of the iceberg' of the cost impact on society.

31 Jul 2019

Study analyzes the prevalence of antipsychotic use in youths with ADHD

Although fewer young people with ADHD are treated with antipsychotic drugs than suspected, many prescriptions for the drugs do not appear to be clinically warranted, according to a new study from psychiatry researchers at Columbia University Vagelos College of Physicians and Surgeons.

26 Jul 2019

Study could lead to new strategies for slowing the growth of glioblastoma

Researchers are hopeful that new strategies could emerge for slowing the growth and recurrence of the most common primary brain cancer in adults, glioblastoma, based on the results of a study published today in Cancer Research.

10 Jul 2019

Study: Treatment of psychosis can be targeted to specific genetic mutation

Treatment of psychosis can be targeted to a specific genetic mutation in patients with psychotic disorders, according to a study in Biological Psychiatry, published by Elsevier.

4 Jul 2019

Targeted treatment offers symptom relief for patients with psychosis

Treatment for individuals who experience psychosis, such as hallucinations and delusions as a result of a psychiatric illness, can be targeted to a specific structural mutation, according to a study published by researchers from McLean Hospital and other institutions in the journal Biological Psychiatry.

3 Jul 2019

Better care needed for people experiencing first manic episode, say researchers

Better care and more research into treatments for people experiencing a first manic episode are urgently needed, according to researchers at the NIHR Maudsley Biomedical Research Centre.

25 Jun 2019

Georgia researcher receives grant to develop models to better predict mental health disorders

Vince Calhoun, Distinguished University Professor of Psychology at Georgia State University and director of the Center for Translational Research in Neuroimaging and Data Science, has received nearly $4 million from the National Institutes of Health's National Institute of Mental Health to develop new models that use brain imaging and genomic data to better predict mental health disorders

18 Jun 2019